Literature DB >> 27690267

Effect of feed supplementation with kynurenic acid on the morphology of the liver, kidney and gills in rainbow trout (Oncorhynchus mykiss Walbaum, 1792), healthy and experimentally infected with Yersinia ruckeri.

E Kaczorek1, J Szarek2, M Mikiewicz3, E Terech-Majewska4, P Schulz1, J Małaczewska1, R Wójcik1, A K Siwicki5.   

Abstract

Kynurenic acid (KYNA) is an endogenous substance produced on the kynurenine pathway which is primarily known for its neuroactive properties. Recently, it has been proven that KYNA is a selective ligand for G protein-coupled receptor (GPR 35), presented on immunocompetent cells such as T lymphocytes. This opens up new possibilities of its application as an immunostimulating substance in aquaculture. Thus far, no histopathological investigations in fish have been completed to evaluate influence of KYNA supplementation in feed. This study has been undertaken to determine the effect of feed supplementation with KYNA (2.5, 25, 250 mg kg-1 of feed) for 28 days on the liver, gills and kidney in healthy fish and experimentally infected with Yersinia ruckeri. In a control group were observed a fatty liver, which is natural for this fish species in the autumn and winter season. As the dose of the supplement was increased, the fat liver changed, it decreased or completely disappeared. Additionally, inflammatory changes occurred in all the analysed organs, and their intensification was dose dependent. In the fish experimentally infected, KYNA caused aggravation of the signs in the liver, kidneys and gills, and the effect was dose dependent. The results implicate that KYNA may be a stressor for fish.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  gills; kidney; kynurenic acid; liver; rainbow trout

Mesh:

Substances:

Year:  2016        PMID: 27690267     DOI: 10.1111/jfd.12567

Source DB:  PubMed          Journal:  J Fish Dis        ISSN: 0140-7775            Impact factor:   2.767


  5 in total

Review 1.  An Emerging Cross-Species Marker for Organismal Health: Tryptophan-Kynurenine Pathway.

Authors:  Laiba Jamshed; Amrita Debnath; Shanza Jamshed; Jade V Wish; Jason C Raine; Gregg T Tomy; Philippe J Thomas; Alison C Holloway
Journal:  Int J Mol Sci       Date:  2022-06-04       Impact factor: 6.208

2.  Angiotensin II type 1 receptor blockers decrease kynurenic acid production in rat kidney in vitro.

Authors:  Izabela Zakrocka; Katarzyna M Targowska-Duda; Artur Wnorowski; Tomasz Kocki; Krzysztof Jóźwiak; Waldemar A Turski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-10-29       Impact factor: 3.000

3.  Kynurenic Acid and Its Analogs Are Beneficial Physiologic Attenuators in Bdelloid Rotifers.

Authors:  Zsolt Datki; Zita Galik-Olah; Zsuzsanna Bohar; Denes Zadori; Ferenc Fulop; Istvan Szatmari; Bence Galik; Janos Kalman; Laszlo Vecsei
Journal:  Molecules       Date:  2019-06-10       Impact factor: 4.411

Review 4.  Kynurenic Acid: The Janus-Faced Role of an Immunomodulatory Tryptophan Metabolite and Its Link to Pathological Conditions.

Authors:  Elisa Wirthgen; Andreas Hoeflich; Alexander Rebl; Juliane Günther
Journal:  Front Immunol       Date:  2018-01-10       Impact factor: 7.561

5.  Analysis of the Long-Lived Responses Induced by Immunostimulants and Their Effects on a Viral Infection in Zebrafish (Danio rerio).

Authors:  Margarita Álvarez-Rodríguez; Patricia Pereiro; Felipe E Reyes-López; Lluis Tort; Antonio Figueras; Beatriz Novoa
Journal:  Front Immunol       Date:  2018-07-09       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.